Lower frequency of IL-17F sequence variant (His161Arg) in chronic fatigue syndrome patients

Biochemical and Biophysical Research Communications

Volumn 376, Issue 1, 2008, Pages 231-233

  Metzger, Kristine ^a   Frémont, Marc ^a   Roelant, Chris ^a   De Meirleir, Kenny ^b  

^a Protea Biopharma   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOKINE; HISTAMINE; INTERLEUKIN 17; INTERLEUKIN 17F; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; CYTOKINE RELEASE; ENTEROPATHY; FEMALE; GENETIC POLYMORPHISM; HELPER CELL; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AMINO ACID SUBSTITUTION; ARGININE; FATIGUE SYNDROME, CHRONIC; FEMALE; GENE FREQUENCY; HISTIDINE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 52049091641     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.135     Document Type: Article

References (26)

1. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., and Komaroff A. The Chronic Fatigue Syndrome: a comprehensive approach to its definition and study, International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 121 (1994) 953-959
2. Devanur L.D., and Kerr J.R. Chronic Fatigue Syndrome. J. Clin. Vir. 37 3 (2006) 139-150
3. Fletcher M.A., Maher K.J., and Klimas N.G. Natural Killer cell function in chronic fatigue syndrome. Clin. Appl. Immunol. Rev. 2 (2002) 129-139
4. Nijs J., and Frémont M. Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications. Expert Opin. Ther. Targets 12 3 (2008) 281-289
5. Kennedy G., Spence V.A., McLaren M., Hill A., Underwood C., and Belch J.J. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med. 39 5 (2005) 584-589
6. Patarca R. Cytokines and chronic fatigue syndrome. Ann. N.Y. Acad. Sci. 933 (2001) 185-200
7. Skowera A., Cleare A., Blair D., Bevis L., Wessely S.C., and Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin. Exp. Immunol. 135 (2004) 294-302
8. Hanson S.J., Gause W., and Natelson B. Detection of immunologically significant factors for chronic fatigue syndrome using neural-network classifiers. Clin. Diagn. Lab. Immunol. 8 3 (2001) 658-662
9. Visser J., Blauw B., Hinloopen B., Brommer E., De Kloet E.R., Kluft C., and Nagelkerken L. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J. Infect. Dis. 177 2 (1998) 451-454
10. Carlo-Stella N., Badulli C., De Silvestri A., Bazzichi L., Martinetti M., Lorusso L., Bombardieri S., Salvaneschi L., and Cuccia M. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin. Exp. Rheumatol. 24 2 (2006) 179-182
11. Kolls J.K., and Linden A. Interleukin 17 family members and inflammation. Immunity 21 4 (2004) 467-476
12. Matsuzaki G., and Umemura M. IL-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 51 12 (2007) 1139-1147
13. Korn T., Oukka M., Kuchroo V., and Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 19 6 (2007) 362-371
14. Ouyang W., Kolls J.K., and Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28 4 (2008) 454-467
15. Kawaguchi M., Takahashi D., Hizawa N., Suzuki S., Matsukura S., Kokubu F., Maeda Y., Fukui Y., Konno S., Huang S.K., Nishimura M., and Adachi M. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J. Allergy Clin. Immunol. 117 4 (2006) 795-801
16. Maloy K.J. The IL-23/IL-17 axis in intestinal inflammation. J. Intern. Med. 263 6 (2008) 584-590
17. Cheung P.F., Wong C.K., and Lam C.W. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implications for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 180 8 (2008) 5625-5635
18. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., and Murphy K.M. Th17: an effector CD4+ T cell lineage with regulatory T cell ties. Immunity 24 6 (2006) 677-688
19. Seiderer J., Elben I., Diegelmann J., Glas J., Stallhofer J., Tillack C., Pfennig S., Jürgens M., Schmechel S., Konrad A., Göke B., Ochsenkühn T., Müller-Myhsok B., Lohse P., and Brand S. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL-17F p.His161Arg polymorphism in IBD. Inflamm. Bowel Dis. 14 4 (2008) 437-445
20. Logan A.C., Venket Rao A., and Irani D. CFS: lactic acid bacteria may be of therapeutic value. Med. Hypotheses 60 6 (2003) 915-923
21. Maes M., Mihaylova I., and Leunis J.C. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome: indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J. Affect. Disord. 99 1-3 (2007) 237-240
22. Maes M., Coucke F., and Leunis J.C. Normalization of the increased translocation of endotoxin from gram-negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro. Endocrinol. Lett. 28 6 (2007) 739-744
23. Evans H.G., Suddason T., Jackson I., Taams L.S., and Lord G.M. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104 43 (2007) 17034-17039
24. Kattah M.G., Wong M.T., Yocum M.D., and Utz P.J. Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells. Arthritis Rheum. 58 6 (2008) 1619-1629
25. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., and Prat A. Human Th17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13 10 (2007) 1173-1175
26. Bested A.C., Saunders P.R., and Logan A.C. Chronic fatigue syndrome: neurological findings may be related to blood--brain barrier permeability. Med. Hypotheses 57 2 (2001) 231-237